results of the phase iii persist-1 trial of pacritinib for myelofibrosis
Published 9 years ago • 271 plays • Length 3:46Download video MP4
Download video MP3
Similar videos
-
2:04
design and results of persist-1 trial of pacritinib for myelofibrosis
-
1:45
design and results of pacritinib for myelofibrosis trial (persist-1)
-
2:18
results of persist-1 & persist-2 studies of pacritinib vs best alternative therapy in myelofibrosis
-
2:18
updates on persist-1 trial of pacritinib for myelofibrosis
-
1:45
results of the phase 3 persist-1 trial of pacritinib for myelofibrosis
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
3:19
first-line treatment selection in myelofibrosis
-
4:12
pacritinib for patients with mf across the cytopenic spectrum
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
2:03
results of the phase 3 persist-1 trial of pacritinib in myelofibrosis
-
0:54
study design for persist-2 and other upcoming trials of pacritinib
-
3:35
new phase iii trial of imetelstat versus bat in jak inhibitor-refractory myelofibrosis
-
1:17
the use of pacritinib in thrombocytopenic patients with myelofibrosis undergoing allosct
-
1:34
pelabresib in myelofibrosis: the manifest trials
-
1:15
potential approval of pacritinib for the treatment of myelofibrosis
-
1:13
the current bsh guidelines for the diagnosis and evaluation of prognosis of myelofibrosis
-
1:31
risk-adjusted safety analysis of pacritinib for patients with mf
-
2:26
outcomes of patients with accelerated-phase myelofibrosis after reduced-intensity hsct
-
2:15
a phase i study investigating ruxolitinib and abemaciclib for primary or secondary myelofibrosis
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml